This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
The phase for this study is not defined.
Show me locations

The purpose

To study the correlation between the polymorphism of the main immunity genes and progression-free survival in ALCL of the child.

Provided treatments

  • Other: Blood sample

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02902874. The sponsor of the trial is Gustave Roussy, Cancer Campus, Grand Paris and it is looking for 250 volunteers for the current phase.
Official trial title:
Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +